Retrovirus-mediated gene transfer of ornithine-delta-aminotransferase into keratinocytes from gyrate atrophy patients.

Gyrate atrophy is a progressive blindness associated with deficiency of ornithine aminotransferase (OAT). The strategy of using an autologous keratinocyte graft, modified to express high levels of OAT as an ornithine-catabolizing skin-based enzyme sink, is investigated. Two OAT-containing retroviral vectors were constructed with or without a resistance gene. When packaged in a retroviral vector particle generated with the gibbon ape leukemia (GALV) virus envelope (PG13), these vectors could readily transduce >50% of target keratinocytes. The transduced keratinocytes in culture expressed up to 75-fold more OAT than normal control keratinocytes and these gene-modified cells extracted [14C]ornithine more efficiently than controls. The vector prepared without neo transduced cells more efficiently and led to higher levels of OAT expression than the neo-containing vector. Ornithine catabolism was maintained at high levels when the transduced patient keratinocytes were differentiated in vitro as a multilayered cutaneous organoid.

[1]  João Pedro Marques,et al.  Gyrate atrophy of the choroid and retina , 2021, Postgraduate Medical Journal.

[2]  D. Valerio,et al.  Improved screening method for recombinant retrovirus producing clones. , 1996, BioTechniques.

[3]  R. Nussenblatt,et al.  Adenovirus-mediated gene transfer of ornithine aminotransferase in cultured human retinal pigment epithelium. , 1996, Investigative ophthalmology & visual science.

[4]  K. Kurachi,et al.  Loss of expression of a retrovirus-transduced gene in human keratinocytes. , 1996, The Journal of investigative dermatology.

[5]  T. Reynolds,et al.  T–cell mediated rejection of gene–modified HIV–specific cytotoxic T lymphocytes in HIV–infected patients , 1996, Nature Medicine.

[6]  R. Akhurst,et al.  Liposome-medicated gene transfer and expression via the skin. , 1995, Human molecular genetics.

[7]  R. Morgan,et al.  Development and analysis of retroviral vectors expressing human factor VIII as a potential gene therapy for hemophilia A. , 1995, Human gene therapy.

[8]  R. Nussenblatt,et al.  Retrovirus-Mediated Gene Transfer and Expression of Human Ornithine δ-Aminotransferase into Embryonic Fibroblasts , 1994 .

[9]  J. Garlick,et al.  Retrovirus-mediated transduction of cultured epidermal keratinocytes. , 1991, The Journal of investigative dermatology.

[10]  M. Kaiser-Kupfer,et al.  Gyrate atrophy of the choroid and retina. Long-term reduction of ornithine slows retinal degeneration. , 1991, Archives of ophthalmology.

[11]  J. Garcia,et al.  Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus , 1991, Journal of virology.

[12]  A. Nienhuis,et al.  Development of a high-titer retrovirus producer cell line capable of gene transfer into rhesus monkey hematopoietic stem cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. Goff,et al.  A safe packaging line for gene transfer: separating viral genes on two different plasmids , 1988, Journal of virology.

[14]  M. Kaiser-Kupfer,et al.  Visual results of a long-term trial of a low-arginine diet in gyrate atrophy of choroid and retina. , 1981, Ophthalmology.

[15]  A. Beavis,et al.  Factors influencing the activity of ornithine aminotransferase in isolated rat liver mitochondria. , 1977, The Biochemical journal.

[16]  H. Green,et al.  Seria cultivation of strains of human epidemal keratinocytes: the formation keratinizin colonies from single cell is , 1975, Cell.

[17]  J. Phang,et al.  A radioisotopic assay for ornithine-δ-transaminase , 1973 .

[18]  S. Rosenberg,et al.  Interleukin-2-transduced lymphocytes grow in an autocrine fashion and remain responsive to antigen. , 1995, Blood.

[19]  M. Jendoubi,et al.  Correction of ornithine-delta-aminotransferase deficiency in a Chinese hamster ovary cell line mediated by retrovirus gene transfer. , 1995, Gene therapy.